Human kallikrein 8, a novel biomarker for ovarian carcinoma

Cancer Research

Volumn 63, Issue 11, 2003, Pages 2771-2774

  Kishi, Tadaaki ^a,b   Grass, Linda ^a   Soosaipillai, Antoninus ^a   Scorilas, Andreas ^a   Harbeck, Nadia ^c   Schmalfeldt, Barbara ^c   Dorn, Julia ^c   Mysliwiec, Michal ^d   Schmitt, Manfred ^c   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; NEUROPSIN; UNCLASSIFIED DRUG;

ARTICLE; ASCITES FLUID; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION;

ASCITIC FLUID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; FEMALE; HUMANS; IMMUNOASSAY; KALLIKREINS; NEOPLASM STAGING; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038277024     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Diamandis, E. P., Yousef, G. M., Luo, L. Y., Magklara, A., and Obiezu, C. V. The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab., 11: 54-60, 2000.
2. Yousef, G. M., and Diamandis, E. P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev., 22: 184-204, 2001.
3. Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., and Redwine, E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med., 317: 909-916, 1987.
4. Diamandis, E. P., Yousef, G. M., Soosaipillai, A. R., and Bunting, P. Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin. Biochem., 33: 579-583, 2000.
5. Luo, L. Y., Bunting, P., Scorilas, A., and Diamandis, E. P. Human kallikrein 10: a novel tumor marker for ovarian carcinoma? Clin. Chim. Acta, 306: 111-118, 2001.
6. Diamandis, E. P., Okui, A., Mitsui, S., Luo, L. Y., Soosaipillai, A., Grass, L., Nakamura, T., Howarth, D. J., and Yamaguchi, N. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res., 62: 295-300, 2002.
7. Diamandis, E. P., and Yousef, G. M. Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev. Mol. Diagn., 1: 182-190, 2001.
8. Diamandis, E. P., Yousef, G. M., Clements, J., Ashworth, L. K., Yoshida, S., Egelrud, T., Nelson, P. S., Shiosaka, S., Little, S., Lilja, H., Stenman, U. H., Rittenhouse, H. G., and Wain, H. New nomenclature for the human tissue kallikrein gene family. Clin. Chem., 46: 1855-1858, 2000.
9. Yoshida, S., Taniguchi, M., Hirata, A., and Shiosaka, S. Sequence analysis and expression of human neuropsin cDNA and gene. Gene, 213: 9-16, 1998.
10. Chen, Z. L., Yoshida, S., Kato, K., Momota, Y., Suzuki, J., Tanaka, T., Ito, J., Nishino, H., Aimoto, S., and Kiyama, H. Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J. Neurosci., 15: 5088-5097, 1995.
11. Okabe, A., Momota, Y., Yoshida, S., Hirata, A., Ito, J., Nishino, H., and Shiosaka, S. Kindling induces neuropsin mRNA in the mouse brain. Brain Res., 728: 116-120. 1996.
12. Momota, Y., Yoshida, S., Ito, J., Shibata, M., Kato, K., Sakurai, K., Matsumoto, K., and Shiosaka, S. Blockade of neuropsin, a serine protease, ameliorates kindling epilepsy. Eur. J. Neurosci., 10: 760-764, 1998.
13. Komai, S., Matsuyama, T., Matsumoto, K., Kato, K., Kobayashi, M., Imamura, K., Yoshida, S., Ugawa, S., and Shiosaka, S. Neuropsin regulates an early phase of schaffer-collateral long-term potentiation in the murine hippocampus. Eur. J. Neurosci., 12: 1479-1486, 2000.
14. Shimizu-Okabe, C., Yousef, G. M., Diamandis, E. P., Yoshida, S., Shiosaka, S., and Fahnestock, M. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport, 12: 2747-2751, 2001.
15. Underwood, L. J., Tanimoto, H., Wang, Y., Shigemasa, K., Parmley, T. H., and O'Brien, T. J. Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res., 59: 4435-4439, 1999.
16. Magklara, A., Scorilas, A., Katsaros, D., Massobrio, M., Yousef, G. M., Fracchioli, S., Danese, S., and Diamandis, E. P. The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin. Cancer Res., 7: 806-811, 2001.
17. Kishi, T., Grass, L., Soosaipillai, A., Schimizu-Okabe, C., and Diamandis, E. P. Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin. Chem., 49: 87-96, 2003.
18. Schmalfeldt, B., Prechtel, D., Härthing, K., Späthe, K., Rutke, S., Konik, E., Fridman, R., Berger, U., Schmitt, M., Kuhn, W., and Lengyel, E. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res., 7: 2396-2404, 2001.
19. Yu, H., and Diamandis, E. P. Ultrasensitive time-resolved immunofluorometric assay of prostate-specific antigen in serum and preliminary clinical studies. Clin. Chem., 39: 2108-2114, 1993.
20. Tanimoto, H., Underwood, L. J., Shigemasa, K., Yan Yan, M. S., Clarke, J., Parmley, T. H., and O'Brien, T. J. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer, 86: 2074-2082, 1999.
21. Tanimoto, H., Underwood, L. J., Shigemasa, K., Parmley, T. H., and O'Brien, T. J. Increased expression of protease M in ovarian tumors. Tumor Biol., 22: 11-18, 2001.
22. Luo, L. Y., Katsaros, D., Scorilas, A., Fracchioli, S., Piccinno, R., Rigault de la Longrais, I. A., Howarth, D. J., and Diamandis, E. P. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin. Cancer Res., 7: 2372-2379, 2001.
23. Yousef, G. M., and Diamandis, E. P. Human tissue kallikreins: a new enzymatic cascade pathway? Biol. Chem., 383: 1045-1057, 2002.
24. Woolas, R. P., Conaway, M. R., Xu, F., Jacobs, I. J., Yu, Y., Daly, Davies, A. P., O'Briant, K., Berchuck, A., and Soper, J. T. Combination of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses. Gynecol. Oncol., 59: 111-116, 1995.
25. Mills, G. B., Bast, R. C., Jr., and Srivastava, S. Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics. J. Natl. Cancer Inst. (Bethesda), 93: 1437-1439, 2001.
26. Christensson, A., Laurell, C. B., and Lilja, H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem., 194: 755-763, 1990.
27. Stenman, U. H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K., and Alfthan, O. A complex between prostate-specific antigen and α 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222-226, 1991.